Electric Literature of 110199-16-1, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 110199-16-1, molcular formula is C6H11NS2, introducing its new discovery.
Substituted phenyl sulfonamides as selective beta 3 agonists for the treatment of diabetes and obesity
Substituted phenylsulfonamides are selective beta 3 adrenergic receptor agonists with very little beta 1 and beta 2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted alkyl epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.
Electric Literature of 110199-16-1, Interested yet? Read on for other articles about Electric Literature of 110199-16-1!
Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H705N | ChemSpider